---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-006024"
form_type: "8-K"
ticker: "XAGE"
cik: "0001842939"
company_name: "Longevity Health Holdings, Inc."
filed_at: "2025-01-16T23:59:59+00:00"
generated_at: "2026-05-28T00:17:53.384377+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Carmell closes acquisition of Elevai Skincare; issues ~1.15M shares, $2.5M revenue portfolio

## Summary
- Purchase consideration: ~1.1M shares of Carmell common at $0.8488/sh, plus 117,814 holdback shares for 12-month indemnification.
- Earnout: 5% of annual net sales from existing products for 5 years; $500k milestone if hair/scalp products reach $500k revenue within 24 months.
- Acquired assets include product portfolio with FY2024 revenue ~$2.5M, inventory ~$1.0M, and accounts receivable ~$0.03M.
- Post-closing Carmell common shares outstanding ~30.1M; Chairman expects synergies, expanded portfolio, and improved cash flow.

## SEC filing metadata
- accession: 0000950170-25-006024
- form_type: 8-K
- ticker: XAGE
- cik: 0001842939
- company_name: Longevity Health Holdings, Inc.
- filed_at: 2025-01-16T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842939/000095017025006024/0000950170-25-006024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842939/000095017025006024/ctcx-20250116.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-006024
- JSON: https://secwatch.observer/filing/0000950170-25-006024.json
- Plain text: https://secwatch.observer/filing/0000950170-25-006024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.